With value frameworks still in their infancy, Michael Kolodziej, MD, national medical director for oncology strategy at Aetna, doesn't see how his company can use them just yet. In fact, these frameworks may never be used by insurers, but only for shared decision making between the patient and provider.
With value frameworks still in their infancy, Michael Kolodziej, MD, national medical director for oncology strategy at Aetna, doesn't see how his company can use them just yet. In fact, these frameworks may never be used by insurers, but only for shared decision making between the patient and provider.
Transcript (slightly modified)
Does Aetna plan to leverage the value calculators and frameworks that are no available?
At the present time no. And I think part of that is because they are all works in progress. Now, I will say, and I have said this multiple times, I applaud everybody who is working in this space around their courage, in attempting to objectively define a way of measuring value: having worked in the clinical pathways space for a long time, that was basically the same thing. The better thing now is that people seem to have caught the virus of being interested in quantifying value, but there are some important things missing that make it really, really hard for me to totally embrace them.
The 2 most important things that are missing are the element of real-world evidence—and I think we need to support efforts to collect real-world evidence—and second of all, the patient voice is not adequately represented. I think those are solvable problems and as we look to the next set of iterations we will see attempts to incorporate them. But speaking from the insurance company point of view, I don't see a way that the insurance company is going to use them. But I do see a way that they are going to become an important component of shared decision making at the physician-patient level.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More